$785 Million is the total value of ARMISTICE CAPITAL, LLC's 59 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ZFGN | Exit | ZAFGEN INC | $0 | – | -112,000 | -100.0% | -0.11% | – |
| PDLI | Exit | PDL BIOPHARMA INC | $0 | – | -500,000 | -100.0% | -0.23% | – |
| ARLZ | Exit | ARALEZ PHARMACEUTICALS INC | $0 | – | -700,000 | -100.0% | -0.31% | – |
| TLRDQ | Exit | TAILORED BRANDS INCcall | $0 | – | -160,000 | -100.0% | -0.49% | – |
| WSM | Exit | WILLIAMS SONOMA INC | $0 | – | -52,000 | -100.0% | -0.58% | – |
| DFRG | Exit | DEL FRISCOS RESTAURANT GROUP | $0 | – | -240,000 | -100.0% | -0.90% | – |
| DKS | Exit | DICKS SPORTING GOODS INC | $0 | – | -100,000 | -100.0% | -1.00% | – |
| ABUS | Exit | ARBUTUS BIOPHARMA CORP | $0 | – | -1,600,000 | -100.0% | -1.07% | – |
| SAM | Exit | BOSTON BEER INCcl a | $0 | – | -54,000 | -100.0% | -1.61% | – |
| VSTO | Exit | VISTA OUTDOOR INC | $0 | – | -450,000 | -100.0% | -1.91% | – |
| DECK | Exit | DECKERS OUTDOOR CORP | $0 | – | -172,000 | -100.0% | -2.12% | – |
| KATE | Exit | KATE SPADE & CO | $0 | – | -572,000 | -100.0% | -2.74% | – |
| WFM | Exit | WHOLE FOODS MKT INCcall | $0 | – | -700,000 | -100.0% | -4.30% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.